3rd ESCMID Conference on Vaccines - Vaccines for Mutual Protection


6 - 8 March 2015, Lisbon, Portugal

Final Programme

You can download the pdf file here.

Friday, 6 March 2014

08:00 - 09:00Registration  and Welcome Coffee
09:00 - 09:15

Opening of the Conference by 

Mario Poljak, Susanna Esposito and Ron Dagan

09:15 - 11:00Opening symposium: Mutual protection - the key for disease prevention
Chairpersons: Susanna Esposito (IT), Ron Dagan (IL)
Protection through life – the key role of indirect immunityLiz Miller (UK)
Mutual responses to shared threats: the European RegionRobb Butler (WHO)
The role of surveillance in assuring mutual protection Pier Luigi Lopalco (ECDC)
11:00 - 11:30Coffee Break
11:30 - 13:15Influenza - how best to prevent transmission ofChairpersons: Albert Osterhaus (NL), Keith Klugman (Gates Foundation)
Seasonal influenza vaccines and mutual protection, what are the facts?Chris Chiu (UK)
Pandemic vaccines, are we prepared for the next pandemic? Pier Luigi Lopalco (ECDC)
Universal influenza vaccines, a realistic option? Guus Rimmelzwaan (NL)
13:15 - 14:30Lunch Break
14:30 - 16:15How can we achieve HPV control in Europe?Chairpersons: Paolo Bonanni (IT), Elmar Joura (AT)
Who and when - does it matter for overall population protection?Xavier Castellsagué Piqué (ES)
Cancer, warts or both?Elmar Joura (AT)
Safety and perception - who are the great enemies of HPV vaccination programmes?Paolo Bonanni (IT)
16:15 - 16:45Tea Break
16:45 - 18:00Debate: Are Pneumococcal conjugate vaccine useful in adults, in the presence of widespread pediatric PCV use in Europe?Chairperson: Ake Ortqvist (SE)
ProMarc Bonten (NL)
ConRon Dagan (IL)

Saturday, 7 March 2015

09:00 - 10:45Safety issues in vaccines – potential risk for mutual protectionChairpersons: Litjen Tan (US), Pauline Paterson (UK)
Is EU population protected from polio?Pauline Paterson (UK)
Does the unvaccinated population impact the community they live in? Frederic Bouder (NL)
Does knowledge about mutual protection increase or decrease vaccination behavior?TBC
10:45 - 11:15Coffee Break
11:15 - 13:15Pertussis throughout life – how can we achieve this?Chairpersons: Stanley Plotkin (US), TBC
Current schedules in Europe – how many doses throughout life? Susanna Esposito (IT)
Protection against pertussis in the very young baby – adult vaccines, pre-partum maternal immunization or neonatal immunization? Philippe Duclos (WHO)
Insights from the biology of Bordetella pertussis  and vaccine research to new directions Stanley Plotkin (US)
Live pertussis vaccine – will they provide protection form carriage and spread of pertussis Camille Locht (FR)
13:15 - 14:30Lunch Break
14:30 - 16:15New  insights into prevention of Viral Gastroenteritis in all agesChairpersons: Adam Finn (UK), Timo Vesikari (FI)
Transmission of GIT viral infections – rotavirus and norovirus; potential for herd protection preventionTimo Vesikari (FI)
Challenges to uptake and optimal performance of rotavirus vaccines that might impact herd immunity Umesh Parashar (US)
Vaccines against norovirus – state art; trials in children and adults Hugues Bogaerts (Takeda Pharma)
16:15 - 17:15Poster Discussion and Tea Break
17:15 - 18:30Can we achieve Meningococcal control in Europe?Chairpersons: Juhani Eskola (FI), Lucia Pastore-Celentano (ECDC)
What would be the best schedule for prevention of meningococcal disease in all ages? Ray Borrow (UK)
Can we control all-cause meningococcal disease in Europe? Andrew Pollard (UK)

Sunday, 8 March 2014

09:00 - 10:45Recent threats of Poliovirus - did we open the Pandora box?Chairpersons: Robb Butler (WHO), Liz Miller (UK)
Rapid spread and control of wild poliovirus in highly IPV-vaccinated population - the Israel experienceJacob Moran-Gilad (IL)
Where is surveillance on Poliovirus spread going EuropePaloma Carrillo-Santisteve (ECDC)
Do we need to modify our approach to Poliovirus "end of game" including going for a new improved vaccineDavid Salisbury (UK)
10:45 - 11:15Coffee Break
11:15 - 12:30Debate: universal VZV vaccination to childrenChairpersons: Ron Dagan (IL), Roman Prymula (CZ)
To include the following points
  • Herd protection
  • Reduction of exposure – higher disease in adults?
  • Zoster in adults?
  • Need for adult vaccination with Zoster?

Pro: Adam Finn (UK)

Con: Hanna Nohynek (FI)

12:30 - 12:45Closing Remarks
12:45 - 14:00Farewell Lunch and Departure